ABVC BioPharma Inc

NASDAQ:ABVC  
0.98
+0.04 (+3.77%)
Products, Strategic Combinations

ABVC Biopharma Expands Co-Development Partnership With Rgene Corporation

Published: 06/21/2022 13:36 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Expands Co-development Partnership With Rgene Corporation.
Abvc-unit Entered Clinical Development Service Agreement With Rgene to Guide Three Rgene Drug Products Through Completion of Phase Ii Clinical Studies.
Abvc Biopharma Inc - Under Terms of New Services Agreement, Biokey is Eligible to Receive Payments Totaling $3.0 Million Over a 3-year Period.